Abivax to Begin Testing Experimental Colitis Drug for Covid-19

(Bloomberg) -- French biotech Abivax SA joined the race to find a treatment for the new coronavirus, saying its leading experimental medicine will be tested on about 1,000 high-risk Covid-19 patien...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.